Dr Angelo Di Leo honoured with award

Doctor Angelo Di Leo honoured with award

Partager cette publication

On Friday 27 September, during the opening ceremony of the ESMO conference, Dr Angelo Di Leo will be honoured with the ESMO Lifetime Achievement Award.

This award is given to acknowledge outstanding lifetime achievements in oncology and to recognize research by individuals, that demonstrate commitment to clinical cancer research and education.

 

With a career spanning over three decades, Dr Angelo Di Leo has been dedicated to the treatment and research of breast cancer. He has coordinated several international, pivotal phase III trials in new adjuvant therapies, and has been deeply involved in the evaluation of molecular markers with potential predictive value for breast cancer. He also developed the medical oncology department at the Hospital of Prato, Istituto Toscano Tumori, Italy, transforming it into a leading national center for the treatment of cancer.

A firm believer in the value of independent academic research and international collaboration, Dr Di Leo has been active in the Breast International Group since the beginning and is a member of BIG’s Executive Board.  

During the opening ceremony he will present a keynote lecture entitled “Adjuvant therapy of breast cancer: Targeting tumour biology may not be enough”.

Plus à explorer

Daughters kissing their mother, family spending time together.
Press Release

Results OlympiA trial

Olaparib (Lynparza) in the adjuvant treatment of patients with germline BRCA1/2 mutations and high-risk early breast cancer reduced the risk of cancer recurrence by 42% in OlympiA Phase III

Advanced Breast Cancer; Sixth International Consensus Conference
Nouvelles

ABC6 conference

The 6th International Consensus Conference for Advanced Breast Cancer will take place in November